Terms: = Liver cancer AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677 AND Prognosis
25 results:
1. (2E)-1-(2,4,6-Trimethoxyphenyl)-3-(4-chlorophenyl)prop-2-en-1-one, a Chalcone Derivative, Promotes Apoptosis by Suppressing RAS-ERK and AKT/foxo3a Pathways in Hepatocellular Carcinoma Cells.
Zhang M; Li J; Ma R; Xi J; Xi L; Zhang B; Tian J; Bai Z
Chem Biodivers; 2023 Jul; 20(7):e202300050. PubMed ID: 37314937
[TBL] [Abstract] [Full Text] [Related]
2. Metformin synergistically enhances the antitumour activity of Lenvatinib in hepatocellular carcinoma by altering AKT-foxo3 signalling pathway.
Cheng Y; Zhan P; Lu J; Lu Y; Luo C; Cen X; Wang F; Xie C; Yin Z
Liver Int; 2023 Jul; 43(7):1577-1592. PubMed ID: 37208925
[TBL] [Abstract] [Full Text] [Related]
3. 3-Mercaptopyruvate sulfurtransferase represses tumour progression and predicts prognosis in hepatocellular carcinoma.
Li M; Song X; Jin Q; Chen Y; Zhang J; Gao J; Cen L; Lin Y; Xu C; He X; Li Y; Yu C
Liver Int; 2022 May; 42(5):1173-1184. PubMed ID: 35243746
[TBL] [Abstract] [Full Text] [Related]
4. 6-Shogaol Suppresses the Progression of liver cancer via the Inactivation of Wnt/[Formula: see text]-Catenin Signaling by Regulating TLR4.
Zhang Y; Wang J; Qu Y; Chen Y
Am J Chin Med; 2021; 49(8):2033-2048. PubMed ID: 34961414
[TBL] [Abstract] [Full Text] [Related]
5. ATIC inhibits autophagy in hepatocellular cancer through the AKT/foxo3 pathway and serves as a prognostic signature for modeling patient survival.
Zhang H; Xia P; Liu J; Chen Z; Ma W; Yuan Y
Int J Biol Sci; 2021; 17(15):4442-4458. PubMed ID: 34803509
[No Abstract] [Full Text] [Related]
6. Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of foxo3 Upregulation and Modulation by Regorafenib.
Fondevila F; Méndez-Blanco C; Fernández-Palanca P; Payo-Serafín T; van Pelt J; Verslype C; González-Gallego J; Mauriz JL
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769197
[TBL] [Abstract] [Full Text] [Related]
7. Downregulation of TMEM220 promotes tumor progression in Hepatocellular Carcinoma.
Li T; Guan L; Tang G; He B; Huang L; Wang J; Li M; Bai Y; Li X; Zhang H
Cancer Gene Ther; 2022 Jun; 29(6):835-844. PubMed ID: 34321624
[TBL] [Abstract] [Full Text] [Related]
8. foxo3-induced lncRNA LOC554202 contributes to hepatocellular carcinoma progression via the miR-485-5p/BSG axis.
Yang L; Deng WL; Zhao BG; Xu Y; Wang XW; Fang Y; Xiao HJ
Cancer Gene Ther; 2022 Mar; 29(3-4):326-340. PubMed ID: 33654226
[TBL] [Abstract] [Full Text] [Related]
9. Hypoxia induces sorafenib resistance mediated by autophagy via activating foxo3a in hepatocellular carcinoma.
Liang C; Dong Z; Cai X; Shen J; Xu Y; Zhang M; Li H; Yu W; Chen W
Cell Death Dis; 2020 Nov; 11(11):1017. PubMed ID: 33250518
[TBL] [Abstract] [Full Text] [Related]
10. Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion.
Li R; Deng Y; Liang J; Hu Z; Li X; Liu H; Wang G; Fu B; Zhang T; Zhang Q; Yang Y; Chen G; Liu W
Cell Oncol (Dordr); 2021 Apr; 44(2):279-295. PubMed ID: 33034848
[TBL] [Abstract] [Full Text] [Related]
11. Circular RNA circFBXO11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through miR-605/foxo3/ABCB1 axis.
Li J; Qin X; Wu R; Wan L; Zhang L; Liu R
J Cell Mol Med; 2020 May; 24(9):5152-5161. PubMed ID: 32222024
[TBL] [Abstract] [Full Text] [Related]
12. Transmembrane protein 106C promotes the development of hepatocellular carcinoma.
Luo X; Han G; Lu R; Guan S; Wang Y; Ju L; Chen L; Shao J; Bian Z
J Cell Biochem; 2020 Nov; 121(11):4484-4495. PubMed ID: 32037603
[TBL] [Abstract] [Full Text] [Related]
13. Sirtuin6 (SIRT6) Promotes the EMT of Hepatocellular Carcinoma by Stimulating Autophagic Degradation of E-Cadherin.
Han LL; Jia L; Wu F; Huang C
Mol Cancer Res; 2019 Nov; 17(11):2267-2280. PubMed ID: 31551254
[TBL] [Abstract] [Full Text] [Related]
14. Histone deacetylase SIRT6 regulates chemosensitivity in liver cancer cells via modulation of foxo3 activity.
Hu JQ; Deng F; Hu XP; Zhang W; Zeng XC; Tian XF
Oncol Rep; 2018 Dec; 40(6):3635-3644. PubMed ID: 30542728
[TBL] [Abstract] [Full Text] [Related]
15. Overexpression of Forkhead Box O3a and Its Association With Aggressive Phenotypes and Poor prognosis in Human Hepatocellular Carcinoma.
Ahn H; Kim H; Abdul R; Kim Y; Sim J; Choi D; Paik SS; Shin SJ; Kim DH; Jang K
Am J Clin Pathol; 2018 Jan; 149(2):117-127. PubMed ID: 29365018
[TBL] [Abstract] [Full Text] [Related]
16. miR-182-5p promotes hepatocellular carcinoma progression by repressing foxo3a.
Cao MQ; You AB; Zhu XD; Zhang W; Zhang YY; Zhang SZ; Zhang KW; Cai H; Shi WK; Li XL; Li KS; Gao DM; Ma DN; Ye BG; Wang CH; Qin CD; Sun HC; Zhang T; Tang ZY
J Hematol Oncol; 2018 Jan; 11(1):12. PubMed ID: 29361949
[TBL] [Abstract] [Full Text] [Related]
17. The foxo3/PGC-1β signaling axis is essential for cancer stem cell properties of pancreatic ductal adenocarcinoma.
Kumazoe M; Takai M; Hiroi S; Takeuchi C; Kadomatsu M; Nojiri T; Onda H; Bae J; Huang Y; Takamatsu K; Yamashita S; Kangawa K; Tachibana H
J Biol Chem; 2017 Jun; 292(26):10813-10823. PubMed ID: 28507102
[TBL] [Abstract] [Full Text] [Related]
18. Elucidating the role of the foxo3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
[TBL] [Abstract] [Full Text] [Related]
19. Clinical effects of miR-101 on prognosis of hepatocellular carcinoma and carcinogenic mechanism of anti-miR-101.
Lv X; Li J; Yang B
Oncol Rep; 2016 Oct; 36(4):2184-92. PubMed ID: 27498785
[TBL] [Abstract] [Full Text] [Related]
20. Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via foxo3a activation.
Zhou Y; Liang C; Xue F; Chen W; Zhi X; Feng X; Bai X; Liang T
Oncotarget; 2015 Apr; 6(12):10350-65. PubMed ID: 25871400
[TBL] [Abstract] [Full Text] [Related]
[Next]
